TO did not want to disclose time frame for potential deal for obvious reasons. But did make the point that the discussions with potential partners has been on going for years and the request for phase 1 extension studies from potential partner was answered and successful.
Now if you were waiting on results for an extension study of a potential block buster drug. That was conducted at your request and it succeeds expectations. Would you waste time with securing a deal when market for that drug could be $5B per year once FDA approved by 2028-2030 . The longer they take the less billions they make.
It won’t take long to analyse the new data and confirm this is something very special.
1AD Price at posting:
2.9¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)